Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 118, Issue 1, 2011, Pages 17-23

  Bracken, H ^a   Clark, W ^a   Lichtenberg, E S ^b   Schweikert, S M ^c   Tanenhaus, J ^d   Barajas, A ^c   Alpert, L ^a   Winikoff, B ^a  

^a GYNUITY HEALTH PROJECTS   (United States)

^b Family Planning Associates Medical Group   (United States)

^c Planned Parenthood of San Diego and Riverside Counties   (United States)

^d CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Mifepristone; misoprostol; termination of pregnancy; ultrasound

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADULT; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; ECTOPIC PREGNANCY; FEMALE; GESTATIONAL AGE; HUMAN; HYDATIDIFORM MOLE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTICENTER STUDY; PHYSICAL EXAMINATION; PREGNANCY TERMINATION; PRIORITY JOURNAL; ULTRASOUND;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; DRUG THERAPY, COMBINATION; FEASIBILITY STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PHYSICAL EXAMINATION; PREGNANCY; PROSPECTIVE STUDIES; SELF ADMINISTRATION; ULTRASONOGRAPHY, PRENATAL;

EID: 78650272334     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2010.02753.x     Document Type: Article

References (24)

1. Bartley J, Brown A, Elton R, Baird DT,. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation. Hum Reprod 2001; 16: 2098-102. (Pubitemid 32951901)
2. Winikoff B, Dzuba IG, Creinin MD, Crowden WA, Goldberg AB, Gonzales J, et al. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial. Obstet Gynaecol 2008; 112: 1303-10.
3. Tang OS, Chan CC, Ng EH, Lee SW, Ho PC,. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Hum Reprod 2003; 18: 2315-8.
4. Hamoda H, Ashok PW, Dow J, Flett GM, Templeton A,. A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation. Contraception 2003; 68: 335-8. (Pubitemid 37431121)
5. Gouk EV, Lincoln K, Khair A, Haslock J, Knight J, Cruickshank DJ,. Medical termination of pregnancy at 63 to 83 days gestation. Br J Obstet Gynaecol 1999; 106: 535-9. (Pubitemid 29245583)
6. Ashok PW, Hamoda H, Flett GMM, Kidd A, Fitzmaurice A, Templeton A,. Patient preference in a randomized study comparing medical and surgical abortion at 10-13 weeks gestation. Contraception 2005; 71: 143-8. (Pubitemid 40222068)
7. Ashok PW, Kidd A, Flett GMM, Fitzmaurice A, Graham W, Templeton A,. A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation. Hum Reprod 2002; 17: 92-8. (Pubitemid 34130267)
8. Hamoda H, Ashok PW, Flett GMM, Templeton A,. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. BJOG 2005; 112: 1102-8. (Pubitemid 41632666)
9. Hamoda H, Ashok PW, Flett GMM, Templeton A,. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation. Human Reprod 2005; 20: 2348-54. (Pubitemid 41418530)
10. Hamoda H, Ashok PW, Flett GMM, Templeton A,. Medical abortion at 9-13 weeks' gestation: a review of 1076 consecutive cases. Contraception 2005; 71: 327-32. (Pubitemid 40602308)
11. Fielding SL, Schaff EA, Nam NY,. Clinicians' perception of sonogram indication for mifepristone abortion up to 63 days. Contraception 2002; 66: 27-31.
12. McGalliard C, Gaudoin M,. Routine ultrasound for pregnancy termination requests increases women's choice and reduces inappropriate treatments. Br J Obstet Gynaecol 2004; 11: 79-82. (Pubitemid 38223337)
13. Savitz DA, Terry JW Jr, Dole N, Thorp JM Jr, Siega-Riz AM, Herring AH,. Comparison of pregnancy dating by last menstrual period, ultrasound scanning, and their combination. Am J Obstet Gynecol 2002; 187: 1660-6. (Pubitemid 36026704)
14. Taipale P, Hiilesmaa V,. Predicting delivery date by ultrasound and last menstrual period in early gestation. Obstet Gynecol 2001; 97: 189-94. (Pubitemid 32126331)
15. Mongelli M, Wilcox M, Gardosi J,. Estimating the date of confinement: ultrasonographic biometry versus certain menstrual dates. Am J Obstet Gynecol 1996; 174: 278-81. (Pubitemid 26037724)
16. Ellertson C, Elul B, Ambardekar S, Wood L, Carroll J, Coyaji K,. Accuracy of assessment of pregnancy duration by women seeking early abortions. Lancet 2000; 355: 877-81. (Pubitemid 30137667)
17. Blanchard K, Cooper D, Dickson K, Cullingworth L, Mavimbela N, Von Mollendorf C, et al. A comparison of women's providers' and ultrasound assessments of pregnancy duration among termination of pregnancy clients in South Africa. BJOG 2007; 114: 569-75. (Pubitemid 46587963)
18. Coyaji K, Elul B, Krishna U, Otiv S, Ambardekar S, Bopardikar A, et al. Mifepristone abortion outside the urban research hospital settings in India. Lancet 2001; 357: 120-2. (Pubitemid 32094919)
19. Mol BW, Van Der Veen F, Bossuyt PM,. Symptom-free women at increased risk of ectopic pregnancy: should we screen? Acta Obstet Gynecol Scand 2002; 81: 661-72. (Pubitemid 34827877)
20. Garnhart KT, Simhan H, Kamelle SA,. Diagnostic accuracy of ultrasound above and below the beta hCG discriminatory zone. Obstet Gynecol 1999; 94: 583-7. (Pubitemid 29460944)
21. Hajenius PJ, Mol BW, Ankum WM, Van Der Veen F, Bossuyt PM, Lammes FB,. Suspected ectopic pregnancy expectant management in patients with negative sonographic findings and low serum hCG concentrations. Early Pregnancy 1995; 1: 258-62.
22. Dart RG, Mitterando J, Dart LM,. Rate of change of serial beta-human chorionic gonatropin values as predictive of ectopic pregnancy in patients with indeterminate transvaginal ultrasound findings. Ann Emerg Med 1999; 34: 703-10.
23. Clark W, Bracken H, Tanenhaus J, Schweikert S, Lichtenberg S, Winikoff B,. Alternatives to a routine follow-up visit for early medical abortion. Obstet Gynecol 2010; 115: 264-72.
24. Grossman D, Ellertson C, Grimes D, Walker D,. Routine follow-up visits after first-trimester induced abortion. Obstet Gynecol 2004; 103: 738-45. (Pubitemid 40459036)